🚨Our latest invited review is now live 📣! Explore the current controversies in managing intermediate risk #thyroid cancer 👇🏻 Juan P Brito Mayo Clinic Endocrinology AACE #Endotwitter #Medtwitter endocrinepractice.org/article/S15308…

🚨 Exciting News for #Thyroid Specialists! 🚨 Join us next Friday for an insightful #TIROxMDs session featuring the brilliant Dr. Derek O'Keefe (Prof Derek O'Keeffe) 🇮🇪 presenting "RAI (Responsible Artificial Intelligence) in Thyroid Disease" with an expert discussion led by Dr.

New Insights into the heated debate: Treating Subclinical #Hypothyroidism and #Thyroid Autoimmunity in #Pregnancy-Open access pubmed.ncbi.nlm.nih.gov/39084813/

Wonderful collaboration with Rachel Pessah-Pollack, M.D., F.A.C.E. and so proud of this publication American Thyroid Association AACE Endocrine Society U-M Endocrinology Michigan Medicine

Excited to share our results VA HSR VA Research showing LT4 overuse & potential disparities. Frequency and Determinants of #Levothyroxine Therapy Initiation for #Veterans with Subclinical Hypothyroidism mdpi.com/2972918 JCM MDPI American Thyroid Association Endocrine Society AACE

Adoption of #AI in #Thyroidology. Excellent presentations at #ATA2024 ⁦Juan P Brito⁩ ⁦Naykky Singh Ospina⁩

Ringing in the new year with publication in Endocrine Practice! AACE Our study 🔍 introduces a predictive model for Graves' disease recurrence after antithyroid therapy 💊, featuring a nomogram for bedside clinical use. 🏥 (thread ⬇️) tinyurl.com/58uufx3u #GravesDisease

📈 Key findings that increase recurrence risk: Age: Each decade increases risk by 31% (HR 1.31). Baseline Free T4: Every 2.0 ng/dL rise boosts risk by 65% (HR 1.65). Continued 👇

📊 Our nomogram integrates these and other variables, guiding personalized treatment decisions! What is this patient's risk of recurrence? Examples using the full Graves' Disease nomogram (see 👇)

You see the following patients in your clinic. 1️⃣ 40 y/o female (+25 pts) Smoker 🚬 (+18.7 pts) FT4: 4 ng/dL (+30.1 pts) Age: 40 years (+25 pts) Duration ⏰ of ATD: 12 months (+41 pts) 🔢 Total: 122 pts ➡️ 70% risk Compare this to patient #2 (see 👇)

🚨Do GLP-1RAs increase thyroid cancer risk? Our editorial reviews new global data to address this critical question 📄 Read more: liebertpub.com/doi/10.1089/th… Naykky Singh Ospina Juan P Brito Mayo Clinic UFEndocrinology Thyroid Journal American Thyroid Association

Our latest research suggests GLP-1RA might not cause thyroid cancer but increase its detection during the first year of use: More ultrasounds than controls during the first year = more thyroid cancer diagnoses ja.ma/40IofZe Juan P Brito Rozalina (Grubina) McCoy, MD MS Mayo Clinic Endocrinology

This was a team effort including the IS faculty and scholars, special thanks to Sara J. Landes, PhD, @CAVHS and UAMS research team Eva Woodward, PhD Richard Owen, MD and external collaborators from Mayo Clinic Juan P Brito and University of Florida Naykky Singh Ospina

How well can we predict which patients with #GravesDisease will recur after remission? Read the March issue review by Joris Ospinga of a new paper from authors at #MayoClinic. ow.ly/Hbzk50Vyqn5 #medtwitter #endotwitter #hyperthyroidism AACE Graves' Disease & Thyroid Foundation

Thank you AACE for highlighting our work. Our study 🔍 introduces a predictive model for Graves' disease recurrence after antithyroid therapy 💊, featuring a nomogram for bedside clinical use. 🏥 Check out this thread: x.com/o_kawkgi/statu…

Optimal Thyroid Hormone Management: How Do We Get There? #AACE2025 excellent session with experts in the field Juan P Brito

Proud of our endocrine fellows UAMS CAVHS #UAMSEndocrinology #AACE2025 #Endotwitter

Excellent #SCH lecture by Spyridoula Maraka at the insightful #Thyroid clinical session #AACE2025 chaired by Maria Papaleontiou, MD 🩺

Excellent team for the thyroid ultrasound workshop #AACE2025 AACE

Still taking it in—honored to receive the Rising Star in Endocrinology Award at #AACE2025! Huge thanks to @AACE and to every mentor, colleague, and friend who’s been part of this journey. Excited and motivated to keep pushing the field forward! #EndoTwitter VA Research UAMS